Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: Its dual inhibitory effects on the ligands and the receptors

Cellular Immunology

Volumn 228, Issue 1, 2004, Pages 27-33

  Kobayashi, Miwa ^a   Shimauchi, Takatoshi ^a   Hino, Ryosuke ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chemokine; Keratinocyte; Roxithromycin; Th2

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 2; ROXITHROMYCIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SKIN ALLERGY; TH1 CELL; TH2 CELL;

CELL LINE; CHEMOKINES; CHEMOKINES, CC; DOWN-REGULATION; GENE EXPRESSION; HUMANS; KERATINOCYTES; LIGANDS; RECEPTORS, CHEMOKINE; ROXITHROMYCIN; TH2 CELLS;

BACTERIA (MICROORGANISMS);

EID: 2942558834     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.03.011     Document Type: Article

References (26)

1. Ohshima A., Tokura Y., Wakita H., Furukawa F., Takigawa M. Roxithromycin down-modulates antigen-presenting and interleukin-1β-producing abilities of murine Langerhans cells. J. Dermatol. Sci. 17:1998;214-222
2. Wakita H., Tokura Y., Furukawa F., Takigawa M. The macrolide antibiotic, roxithromycin suppresses IFN-γ-mediated immunological functions of cultured normal human keratinocytes. Biol. Pharm. Bull. 19:1996;224-227
3. + cell changes in psoriasis associated with roxithromycin-induced clinical improvement. Eur. J. Dermatol. 11:2001;410-415
4. Tokura Y., Sugaya K., Kageyama H., Wakita H., Furukawa F., Takigawa M., Ito T., Nakano M. Inhibitory effect of roxithromycin on the myeloperoxidase activity of peripheral polymorphonuclear leukocytes: its evaluation in patients with psoriasis and pustulosis palmaris et plantaris. Jpn. J. Inflamm. 15:1995;461-465
5. Komine M., Tamaki K. An open trial of oral macrolide treatment for psoriasis vulgaris. J. Dermatol. 27:2000;508-512
6. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242
7. Tokuriki A., Seo N., Ito T., Kumakiri M., Takigawa M., Tokura Y. Dominant expression of CXCR3 is associated with induced expression of IP-10 at hapten-challenged sites of murine contact hypersensitivity: a possible role for interferon-γ-producing CD8 (+) T cells in IP-10 expression. J. Dermatol. Sci. 28:2002;234-241
8. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:1998;875-883
9. Boorsma D.M., Flier J., Sampat S., Ottevanger C., de Haan P., Hooft L., Willemze R., Tensen C.P., Stoof T.J. Chemokine IP-10 expression in cultured human keratinocytes. Arch. Dermatol. Res. 290:1998;335-341
10. + lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115:2000;640-646
11. Xiao T., Kagami S., Saeki H., Sugaya M., Kakinuma T., Fujita H., Yano S., Mitsui H., Torii H., Komine M., Asahina A., Nakamura K., Tamaki K. Both IL-4 and IL-13 inhibit the TNF-α and IFN-γ enhanced MDC production in a human keratinocyte cell line, HaCaT cells. J. Dermatol. Sci. 31:2003;111-117
12. Albanesi C., Scarponi C., Sebastiani S., Cavani A., Federici M., De Pita O., Puddu P., Girolomoni G. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J. Immunol. 165:2000;1395-1402
13. Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., Sayama K., Hashimoto K. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J. Dermatol. Sci. 31:2003;37-42
14. Kuroda E., Sugiura T., Okada K., Zeki K., Yamashita U. Prostaglandin E2 up-regulates macrophage-derived chemokine production but suppresses IFN-inducible protein-10 production by APC. J. Immunol. 166:2001;1650-1658
15. Barker J.N., Sarma V., Mitra R.S., Dixit V.M., Nickoloff B.J. Marked synergism between tumor necrosis factor-α and interferon-γ regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J. Clin. Invest. 85:1990;605-608
16. Papadavid E., Economidou J., Psarra A., Kapsimali V., Mantzana V., Antoniou C., Limas K., Stratigos A., Stavrianeas N., Avgerinou G., Katsambas A. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sezary syndrome. Br. J. Dermatol. 148:2003;709-718
17. Kakinuma T., Sugaya M., Nakamura K., Kaneko F., Wakugawa M., Matsushima K., Tamaki K. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J. Am. Acad. Dermatol. 48:2003;23-30
18. + T cells. J. Am. Acad. Dermatol. 43:2000;946-954
19. Ohmori Y., Schreiber R.D., Hamilton T.A. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272:1997;14899-14907
20. Sallusto F., Kremmer E., Palermo B., Hoy A., Ponath P., Qin S., Forster R., Lipp M., Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. Eur. J. Immunol. 29:1999;2037-2045
21. Dorado B., Portoles P., Ballester S. NF-κB in Th2 cells: delayed and long-lasting induction through the TCR complex. Eur. J. Immunol. 28:1998;2234-2244
22. Leung D.Y. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96:1995;302-318. quiz 319
23. Tokura Y., Yagi H., Hanaoka K., Ito T., Towyama K., Sachi Y., Tanaka M., Sakamoto T., Sekizuka T., Furukawa F., Takigawa M. Subacute and chronic prurigo effectively treated with recombination interferon-γ: implications for participation of Th2 cells in the pathogenesis of prurigo. Acta Dermatol. Venereol. 77:1997;231-234
24. Fushimi M., Tokura Y., Sachi Y., Hashizume H., Sudo H., Wakita H., Furukawa F., Takigawa M. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br. J. Dermatol. 134:1996;766-772
25. - T cells expressing interleukin-5 mRNA. Br. J. Dermatol. 136:1997;918-923
26. Katagiri K., Itami S., Hatano Y., Yamaguchi T., Takayasu S. In vivo expression of IL-4, IL-5, IL-13 and IFN-γ mRNAs in peripheral blood mononuclear cells and effect of cyclosporin A in a patient with Kimura's disease. Br. J. Dermatol. 137:1997;972-977